Prostatectomy News and Research

RSS

Calcium intake could be used as a prognostic factor for osteoporosis

Measuring a man's daily calcium intake is an effective way of identifying prostate cancer patients with a higher than average risk of osteoporosis, according to the April issue of the urology journal BJU International.

11 Apr 2007

Emotional stress may contribute to development of cancer and may also reduce effectiveness of treatments

Scientists from Wake Forest University School of Medicine are the first to report that the stress hormone epinephrine causes changes in prostate and breast cancer cells that may make them resistant to cell death.

11 Apr 2007

Research shows relationship between low calcium intake and higher levels of osteoporosis in men with prostate cancer

Daily calcium intake is an effective way of identifying prostate cancer patients with a higher than average risk of osteoporosis, according to the April issue of the urology journal BJU International.

11 Apr 2007

PSA doubling time and indicator of recurrent prostate cancer

A detectable level of prostate-specific antigen (PSA) is the first indicator of recurrent prostate cancer after radical prostatectomy.

10 Apr 2007

Obesity at the time of prostate-cancer diagnosis dramatically increases the risk of dying from the disease

Obese men who are diagnosed with prostate cancer have more than two-and-a-half times the risk of dying from the disease as compared to men of normal weight at the time of diagnosis, according to a study by researchers at Fred Hutchinson Cancer Research Center.

15 Mar 2007

Life expectancy doubled for advanced prostate cancer patients

After being diagnosed with aggressive prostate cancer, many men are told that their disease is untreatable and that less aggressive treatment is best.

11 Mar 2007

Prostate brachytherapy causes fewer side effects than surgery

Men with prostate cancer have a slightly better long-term side effects profile with radiation seed implants than they do with surgery, according to a study released today in the International Journal for Radiation Oncology-Biology-Physics, the official journal of ASTRO.

28 Feb 2007

Long-term oncologic outcomes: A 40 year radical prostatectomy single institution series

Single institution long-term outcomes for radical prostatectomy are scarce in the literature. In the August 2006 issue of the Journal of Urology, Dr. Porter from the Virginia Mason Medical Center, Seattle, WA reports on 25-year cancer outcomes for radical prostatectomy (RP).

6 Sep 2006

Variances in patterns of care for patients with prostate cancer failing primary therapy

Variables that impact management of failed primary therapy for prostate cancer (CaP) are not well defined.

21 Aug 2006

Pomegranate juice may decrease PSA progression in patients with cancer recurrence after treatment

Because of their high content of antioxidants, pomegranate juice is frequently recommended for cancer prevention and overall wellness. While small studies have suggested a role against prostate carcinogenesis, no organized trials have been published until now.

17 Aug 2006

The role of transurethral resection of the prostate and biopsy of the peripheral zone after pepeated negative biopsies in the diagnosis of prostate cancer examined

Persistent suspicion of prostate cancer despite repeated negative prostate biopsies is a common problem in urologic practice.

15 Aug 2006

Biomira Stimuvax prostate cancer study results published

Biomira Inc. has announced publication of study results showing that Stimuvax, formerly known as BLP25 Liposome Vaccine or L-BLP25, could slow rising Prostate Specific Antigen (PSA) levels in some post-surgical prostate cancer patients

20 Jul 2006

New diagnostic tool for prostate cancer

According to the World Health Organization there are about 250,000 new cases of prostate cancer every year but, when caught in time, the disease has a cure rate of over 90%.

19 Jul 2006

A new diagnostic tool for prostate cancer

According to the World Health Organization there are about 250,000 new cases of prostate cancer every year but, when caught in time, the disease has a cure rate of over 90%.

12 Jul 2006

Parameters associated with patient outcomes in lymph node positive prostate cancer

Dr. Hofer and colleagues report in the June issue of Urology that lymphovascular invasion (LVI) and the nuclear grade of the primary prostate tumor are independent predictors of PSA recurrence in men with lymph node positive CaP.

3 Jul 2006

Study examines the use of a novel suprapubic catheter in suprapubic prostatectomy

It is well known that in addition to urethral catheter associated discomfort, there is an increased risk of ascending urethral infection, inflammation and stricture formation with urethral catheters.

29 Jun 2006

Obesity associated with less favorable outcome after radiation therapy for prostate cancer

Obese men with prostate cancer are at higher risk for treatment failure after primary radiation therapy, according to a new study.

27 Jun 2006

For men with prostate cancer, treatment information fails to address fears

Men with prostate cancer make emotionally driven treatment decisions influenced by anecdote and misconception rather than consideration of clinical trial evidence, according to a new study.

27 Jun 2006

Few well performed studies address management of lymph node positive prostate cancer

Dr. Gregory Swanson and associates from the University of Texas, San Antonio Health Science Center reviews the data for various treatment options in patients with lymph node positive prostate cancer (CaP).

27 Jun 2006

High surgeon radical prostatectomy volume linked to lower hospital charges

Increased procedure volume by both surgeon and hospital are associated with decreased mortality.

26 Jun 2006

Prostatectomy News and Research

Calcium intake could be used as a prognostic factor for osteoporosis

Emotional stress may contribute to development of cancer and may also reduce effectiveness of treatments

Research shows relationship between low calcium intake and higher levels of osteoporosis in men with prostate cancer

PSA doubling time and indicator of recurrent prostate cancer

Obesity at the time of prostate-cancer diagnosis dramatically increases the risk of dying from the disease

Life expectancy doubled for advanced prostate cancer patients

Prostate brachytherapy causes fewer side effects than surgery

Long-term oncologic outcomes: A 40 year radical prostatectomy single institution series

Variances in patterns of care for patients with prostate cancer failing primary therapy

Pomegranate juice may decrease PSA progression in patients with cancer recurrence after treatment

The role of transurethral resection of the prostate and biopsy of the peripheral zone after pepeated negative biopsies in the diagnosis of prostate cancer examined

Biomira Stimuvax prostate cancer study results published

New diagnostic tool for prostate cancer

A new diagnostic tool for prostate cancer

Parameters associated with patient outcomes in lymph node positive prostate cancer

Study examines the use of a novel suprapubic catheter in suprapubic prostatectomy

Obesity associated with less favorable outcome after radiation therapy for prostate cancer

For men with prostate cancer, treatment information fails to address fears

Few well performed studies address management of lymph node positive prostate cancer

High surgeon radical prostatectomy volume linked to lower hospital charges

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News